Also, a study released last week in The New England Journal of Medicine brought the DTC advertising issue back into the spotlight. The authors called for a moratorium on DTC advertising (good for PR?). "Direct-to-consumer advertising spending is increasing in terms of its share of total marketing budget, but it's still a smaller share relative to promotion aimed at influencing prescribers," one of the authors said. PhRMA defended DTC advertising and accused the study of overlooking its educational benefits.
Here's a round up of bloggers thoughts on the DTC issue.